Literature DB >> 6146003

Injectable bromocriptine to treat acute, oestrogen-induced swelling of invasive prolactinoma.

A M Landolt, E del Pozo, J Hayek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6146003     DOI： 10.1016/s0140-6736(84)90287-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.

Authors:  I Halperin; M D Rodriguez; C Cardenal; R Casamitjana; M J Martinez Osaba; V Lienas; E Vilardell
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

2.  Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Authors:  Tracy E Strecker; Thomas J Spady; Beverly S Schaffer; Karen A Gould; Amy E Kaufman; Fangchen Shen; Mac T McLaughlin; Karen L Pennington; Jane L Meza; James D Shull
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

3.  Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.

Authors:  A M Landolt; V Osterwalder; T A Landolt
Journal:  Experientia       Date:  1985-05-15

4.  Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone.

Authors:  E del Pozo; K Schlüter; E Nüesch; J Rosenthaler; L Kerp
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.